Figure 4

Representative immunostaining for the ‘gate region’ of prorenin (a) and the quantitative assessment of renal-activated prorenin (b) at 2 weeks after clipping in two-kidney, one-clip Goldblatt hypertensive rats treated with vehicle (n=3), HRP (n=3) and scramble peptide (n=3).